Combined immunotherapy in children with atopic dermatitis: rationale for application

the study considers advantages of a combination therapy in children with atopic dermatitis (AD) and a rationale for application of multiagent immunotherapy (MIT) including parenteral allergen-specific immunotherapy (PASIT) and an immunomodulator (IM). It has been found that including MIT in the combination therapy of AD for 3 years results in lessening of severity and clinical manifestations of a disease and in improving children's quality of life (QOL).

Authors
Derkach V.V.1, 3 , Slavyanskaya T.A. 3, 2
Publisher
MEDIMOND S R L
Language
English
Pages
63-67
Status
Published
Year
2014
Organizations
  • 1 Pacific State Med Univ, Vladivostok, Russia
  • 2 Peoples Friendship Univ Russia, Moscow, Russia
  • 3 Inst Immunophysiol, Moscow, Russia
Keywords
Atopic dermatitis; children; immunotherapy; allergen-specific immunotherapy; quality of life
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/8431/
Share

Other records